Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Explore key tips for retirement planning to secure your financial future. Understand what steps to take for a comfortable retirement.
26,014 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A ChatGPT-style forecast ranks Bitcoin, XRP, and Ethereum for 2026, placing Bitcoin at the top with a sizable upside,...
Coinbase is guiding certain Commerce wallet users to a seed-phrase recovery path ahead of a March 31, 2026 shutdown, ...
Intel is resetting expectations around AI with a focus on edge infrastructure and domestic manufacturing, signaling a...
Lemonade stock surged about 16% this week thanks to a powerful mix of analyst optimism and progress in its AI-based u...
Kevin O’Leary’s $4.2 billion Softkey exit in 1999 turned him into a millionaire, but the moment was surprisingly low-...
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Amazon unveils a bold plan to expand Leo satellites, targeting 1 Gbps speeds and enterprise deals that could disrupt ...
Alibaba's profits falling here's headlines grab attention, but the real story is a company in transition. This guide ...
Arm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...
Alix Earle launches Reale Actives, a skincare line built for acne-prone skin, marking her move from viral creator to ...
AI is reshaping the data center landscape, and Marvell is at the center of the action. This piece breaks down why mar...